Testing effectiveness (Phase 2)Study completedNCT00118625
What this trial is testing
Assessment of the Contribution of Monophosphoryl Lipid A (MPL) to a Tree Pollen Allergy Vaccine
Who this might be right for
Type I Hypersensitivity
Allergy Therapeutics 40